Faculty of 1000 Biology | Faculty member: Peter Wiernik

4-Jul-2008

	Peter Wiernik Department of Dermatology, New York Medical Center, United States of America
	Faculty Member: PHARMACOLOGY & DRUG DISCOVERY > Cancer therapeutics [ since 30 May 2007 ]

email [Help]

Evaluations

Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells.
Weisberg E, Wright RD, …, Kung AL, Griffin JD
Mol Cancer Ther 2008 Apr 29 [abstract on PubMed] [related articles] [full text]

Selected by | Peter Wiernik
Evaluated 6 May 2008

Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study.
Rubnitz JE, Wichlan D, …, Pullen J, Children's Oncology Group
J Clin Oncol 2008 May 1 26(13):2186-91 [abstract on PubMed] [related articles] [full text] [order article]

Selected by | Peter Wiernik
Evaluated 6 May 2008

Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride.
Teichert J, Baumann F, …, Patzak U, Preiss R
Cancer Chemother Pharmacol 2007 May 59(6):759-70 [abstract on PubMed] [related articles] [full text] [order article]

Selected by | Peter Wiernik
Evaluated 8 Jan 2008

Bendamustine induces G2 cell cycle arrest and apoptosis in myeloma cells: the role of ATM-Chk2-Cdc25A and ATM-p53-p21-pathways.
Gaul L, Mandl-Weber S, …, Emmerich B, Schmidmaier R
J Cancer Res Clin Oncol 2008 Feb 134(2):245-53 [abstract on PubMed] [related articles] [full text] [order article]

Selected by | Peter Wiernik
Evaluated 7 Jan 2008

Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection.
Miyazaki T, Fujimaki K, …, Hotta T, Ishigatsubo Y
Am J Hematol 2007 Dec 82(12):1106-9 [abstract on PubMed] [related articles] [full text] [order article]

Selected by | Peter Wiernik
Evaluated 16 Aug 2007

High levels of serum prostate-specific antigen due to PSA producing follicular non-Hodgkin's lymphoma.
Oosterheert JJ, Budel LM, Vos P, Wittebol S
Eur J Haematol 2007 Aug 79(2):155-8 [abstract on PubMed] [related articles] [full text] [order article]

Selected by | Peter Wiernik
Evaluated 16 Aug 2007

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients.
Pellagatti A, Jädersten M, …, Boultwood J, Hellström-Lindberg E
Proc Natl Acad Sci U S A 2007 Jul 3 104(27):11406-11 [abstract on PubMed] [related articles] [FREE full text]

Selected by | Peter Wiernik
Evaluated 26 Jun 2007